We are talking options on assets that the purchaser must buy or sell at the price set out  – or to be determined according to the formulas set out – in the agreement.

What aspects need to be examined to assess the impact of Covid-19 on these agreements?

What remedies are provided by law if the crisis has caused a lack of liquidity that prevents a party from fulfilling its obligations or an imbalance in the contract or downstream?

If you would like a copy of the answers prepared by our Private Equity Focus Team, in coordination with the Covid-19 Task Force, just email covid19@belex.com.